CFDA: FDA Latest Computer Systems Warning Letters

WL Issued to Amrex Zetron Inc
FDA Tue, 14 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Amrex Zetron Inc on 14 Apr 2009 by Los Angeles District Office
WL Issued to Coast Institutional Review Board
FDA Tue, 14 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Coast Institutional Review Board on 14 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Branitz, Bruce, MD
FDA Thu, 09 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Branitz, Bruce, MD on 09 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Cote, Charles J., MD
FDA Mon, 02 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Cote, Charles J., MD on 02 Mar 2009 by Center for Drug Evaluation and Research
WL Issued to Genzyme Corporation
FDA Fri, 27 Feb 2009 00:00:00 -0400
FDA Warning Letter Issued to Genzyme Corporation on 27 Feb 2009 by New England District Office
WL Issued to Hammill Manufacturing Company
FDA Tue, 06 Jan 2009 00:00:00 -0400
FDA Warning Letter Issued to Hammill Manufacturing Company on 06 Jan 2009 by Cincinnati District Office

CFDA: FDA Latest Drug GCP Warning Letters

WL Issued to Coast Institutional Review Board
FDA Tue, 14 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Coast Institutional Review Board on 14 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Branitz, Bruce, MD
FDA Thu, 09 Apr 2009 00:00:00 -0400
FDA Warning Letter Issued to Branitz, Bruce, MD on 09 Apr 2009 by Center for Drug Evaluation and Research
WL Issued to Bukowski, Ronald M, MD
FDA Mon, 30 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Bukowski, Ronald M, MD on 30 Mar 2009 by Center for Drug Evaluation and Research
WL Issued to Youabian, Inc
FDA Tue, 17 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Youabian, Inc on 17 Mar 2009 by Los Angeles District Office
WL Issued to Provena St. Joseph's Medical Center IRB
FDA Thu, 12 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Provena St. Joseph's Medical Center IRB on 12 Mar 2009 by Center for Biologics Evaluation and Research
WL Issued to Paulson, Daniel M., MD
FDA Wed, 11 Mar 2009 00:00:00 -0400
FDA Warning Letter Issued to Paulson, Daniel M., MD on 11 Mar 2009 by Center for Drug Evaluation and Research

 

Subscribe to Drugs_and_Medications RSS feed

DrugDigest: Imatinib ( Gleevec ) - Information on dosage, usage, side effects, interactions, and drug comparisons including generics when available.

Gleevec - Imatinib mesylate. Features prescribing and reimbursement information for US residents.
Meta Description: [ How Gleevec works. Gleevec is used to treat Chronic Myeloid Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST). ]

Gleevec Consumer Information - FDA - Patient FAQ in html format with a link to approved labeling in pdf format.

Gleevec Information - Features information from the FDA's Center for Drug Evaluation and Research including news releases, FAQs, approval letter, and draft package insert.
Meta Description: [ REPLACE WITH VERBOSE DESCRIPTION ]

Gleevec Resource Center - Features articles, news releases, FAQs, and drug information.
Meta Description: [ Chronic Myelogenous Leukemia Support Home Page. ]

Gleevec's Glory Days - Howard Hughes Medical Institute article, available in HTML and PDF format.

Imatinib ( Glivec ) - International Site - Manufacturer's information on this prescription medication used in the treatment of Chronic Myelogenous Leukemia (CML) and Gastrointestinal Stromal Tumors (GIST).
Meta Description: [ Glivec is a prescription medication used in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST) from Novartis Oncology. On glivec.com international healthcare professionals can learn about CML and GIST, as well as find information on how Glivec treats th... ]

Leukemia-Treatment - Site contains information on Gleevec, CML-Chronic Myeloid Leukemia with monthly updates on new developments from Dr. Brian Druker.

Life Raft Group - Features newsletters from this group of patients who are taking part in the Gleevec trials to treat gastrointestinal stromal tumors, a form of cancer.
Meta Description: [ The Life Raft Group. A patient/caregiver support group for GIST cancer. ]

Newcastle CML - Press release about the STI571 trials in the UK.

Novartis Pharmaceuticals Canada: Gleevec - Prescribing and patient information, from the manufacturer.
Meta Description: [ Novartis Pharmaceuticals Canada Inc. - Our Products - Gleevec ]

STI571 Digest - Reports, news releases, list of current drug trials, and articles from the NIH's National Cancer Institute.
Meta Description: [ A collection of material on STI571 (Gleevec), the first approved drug to directly turn off the signal of a protein known to cause a cancer. ]

Unofficial Gleevec Site - Features a history of the drug, interviews with medical professionals, message boards, FAQs, news, and an album of thank yous to Dr. Druker, Gleevec's primary researcher.
Meta Description: [ sti571, sti-571, Gleevec, Glivec, leukemia, chronic myelogenous leukemia, cml, gist, c-kit, gastrointestinal stromal tumor, leiomyosarcoma, cancer, tyrosine kinase inhibitor, cgp57148b, cgp57148, sti571, sti-571, Gleevec, Glivec, leukemia, chronic myelogenous leukemia, cml, gist, c-kit, gastroint... ]

Yahoo! Groups: Gleevec - Discussion forum for anyone interested in Gleevec treatments.
Meta Description: [ Gleevec: Gleevec ]